Fortis Healthcare has received final approval from the BSE for modifications or alterations to the terms of its debentures. The announcement, dated December 19, 2025, confirms that the company has successfully concluded the process of updating the debenture terms. This move is expected to provide greater flexibility and potentially improve the financial structure of the company concerning its debt obligations.
BSE Approval Received
Fortis Healthcare Limited announced on December 19, 2025, that it has received the final approval from the Bombay Stock Exchange (BSE) regarding modifications to the terms of its debentures.
Impact on Debentures
The approval allows Fortis Healthcare to implement the proposed modifications and alterations to the existing terms and conditions related to its debentures. These changes are anticipated to optimize the company’s financial arrangements and provide greater operational flexibility concerning its debt structure. The company had initially intimated about this on December 4, 2025.
Source: BSE
